期刊文献+

奥沙利铂和替吉奥联合参苓白术散治疗晚期胃癌的临床效果观察 被引量:3

下载PDF
导出
摘要 目的探讨奥沙利铂和替吉奥联合参苓白术散治疗晚期胃癌的近期效果和患者生活质量改善情况。方法随机将80例晚期胃癌患者分为2组,每组40例。对照组给予奥沙利铂和替吉奥治疗,观察组在对照组基础上联合中药治疗。每个疗程21 d,6个疗程后,评价2组患者的治疗效果。结果 2组患者的近期治疗有效率比较,差异无统计学意义(P>0.05)。但观察组患者的生活质量评分显著优于对照组,差异有统计学意义(P<0.05)。结论对晚期胃癌患者在行奥沙利铂和替吉奥治疗的同时,联合参苓白术散治疗,能显著提高患者的生活质量。
出处 《河南外科学杂志》 2017年第3期93-94,共2页 Henan Journal of Surgery
  • 相关文献

参考文献6

二级参考文献62

  • 1陆建伟,周兆飞,尹必俭,刘德林,冯继锋,朱梁军,潘良熹.奥沙利铂联合5-氟尿嘧啶和醛氢叶酸钙时辰治疗晚期胃癌的初步临床研究[J].中华肿瘤杂志,2005,27(11):695-697. 被引量:34
  • 2周金超,李毅忠,程静.紫杉醇与顺铂联合介入治疗膀胱癌的疗效观察[J].中国现代医生,2007,45(05Z):24-24. 被引量:4
  • 3袁泉.羟基脲、替加氟及亚叶酸钙治疗27例晚期鼻咽癌临床观察[J].中国医药导报,2007,4(07Z):54-55. 被引量:14
  • 4Trotti A,Colevas AD, Seteser A, et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment [J]. Semin Radiat Oncol, 2003, 13(3):176-181.
  • 5Tanabe K. Suzuki T, Tokumoto N,et al.Combination therapy with doeetaxel and S-1 as a first-line treatment in patients with advanced or recurrent gastric cancer: a retrospective analysis[J]. World J Surg Oncol, 2010,8:40.
  • 6Higgie GD, Sommadossi JP, Cross DS, et al. Clinical pharmacokinetics of 5-fluorouracil and it metabolites in plasma, urine, and bile [J]. Cancer Res, 1987,47 (8): 2203-2206.
  • 7Beck A, Etienne MC, Cheradame S, et al. A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumor sensitivity to fluorouracil [J]. Eur J Cancer, 1994,30A(10): 1517-1522.
  • 8Fukushima M, Shimamoto Y, Kato T,et al. Anticancer activity and toxicity of S-1, an oral combination of tegafur and two biochemical modulators, compared with continuous i.v. of 5-fluorouracil [J].Anticancer Drugs, 1998,9 (9): 817-823.
  • 9Shirasaka T, Shimamoto Y, Ohshimo H, et al. Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical moderators [J]. Anticancer Drugs, 1996,7(5): 548-557.
  • 10Koizumi W, Kurihara M, Nakano S, et al. Phase Ⅱ study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer. For the S-1 Cooperative Gastric Cancer Study Group [J]. Oncology, 2000, 58 (3): 191- 197.

共引文献51

同被引文献25

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部